The Trump administration has taken an important step toward nominating MD Anderson Cancer Center executive Stephen M. Hahn to the job of FDA commissioner, sources said.
Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising slump in public support.
